Toll样受体在结肠癌发生发展中作用的研究进展
摘要
Toll样受体(Toll-like receptors,TLRs)是天然免疫中重要的模式识别受体(pattern recognition receptor),在启动和调节天然免疫及获得性免疫中起到重要作用。越来越多的研究认为TLRs信号与肿瘤的生物学行为相关,它能通过免疫逃逸、免疫耐受、抵制凋亡等促进肿瘤细胞存活、增殖、迁移,从而促进肿瘤发生发展。
出处
《广东医学》
CAS
CSCD
北大核心
2014年第24期3924-3926,共3页
Guangdong Medical Journal
参考文献25
-
1LEE C C, ANVALOS A M, PLOEGH H L. Accessory molecules for Toll - like receptors and their functio[ J]. Nat Rev Immunol, 2012, 12(3): 168-179. 被引量:1
-
2KIM E J, CHUNG W C, LEE K M, et al. Association between Toll - like receptors/CD14 gene polymorphisms and inflammatory bowel disease in Korean population[ J]. J Korean Med Sci, 2012, 27(1) : 72 -77. 被引量:1
-
3SHCHEBLYAKOV D V, LOGUNOV D Y, TUKHVATULIN A I, et al. Toll -like receptors (TLRs) : the role in tumor progression [J]. Acta Naturae, 2010, 2(3) : 21 -29. 被引量:1
-
4YU C, SHAN T, FENG A, et al. Triptolide ameliorates Crohn's colitis is associated with inhibition of TLRs/NF - kappaB signaling pathway[ Jl. Fitoterapia, 2011, 82(4) : 709 -715. 被引量:1
-
5BASITH S, MANAVALAN B, YOO T H, et al. Roles of Toll - like receptors in cancer: a double - edged sword for defense and offense[J]. Arch Pharm Res, 2012, 35(8) : 1297 -1316. 被引量:1
-
6LU Q, DING H, LI W. Role of Toll - like receptors in microbiota - associated gastrointestinal cancer metastasis [ J 1 J Cancer Res Ther, 2013, 9 Suppl: S142-S149. 被引量:1
-
7SUN S, WANG X, WU X, et al. Toll - like receptor activation by helminths or helminth products to alleviate inflammatory bowel dis- ease[J]. Parasit Vectors, 2011,4: 186. 被引量:1
-
8SEWELL G W, RAHMAN F Z, LEVINE A P, et al. Defective tumor necrosis factor release from Crohn's disease macrophages in response to Toll - like receptor activation: relationship to pheno- type and genome -wide association susceptibility loci[J]. Inflamm Bowel Dis, 2012, 18(11 ) : 2120 -2127. 被引量:1
-
9BERKOW1TZ D, PERI R, LAVY A, et al. Increased Toll - like receptor 9 expression by B cells from inflammatory bowel disease patients[Jl. Hum Immunol, 2013, 74(12) : 1519 - 1523. 被引量:1
-
10RAKHESH M, CATE M, VIJAY R, et al. A TLR4 - interacting peptide inhibits lipopolysaceharide - stimulated inflammatory re- sponses, migration and invasion of colon cancer SW480 cells [ J ]. Oncoimmunology, 2012, 1 (9) : 1495 - 1506. 被引量:1
二级参考文献19
-
1WU S,RHEE K J,ALBESIANO E. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses[J].{H}Nature Medicine,2009,(09):1016-1022. 被引量:1
-
2BISWAS A,WILMANSKI J,FORSMAN H. Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine[J].{H}European Journal of Immunology,2011,(01):182-194. 被引量:1
-
3CAMMAROTA R,BERTOLINI V,PENNESI G. The tumor microenvironment of colorectal cancer:stromal TLR-4 expression as a potential prognostic marker[J].{H}Journal of Translational Medicine,2010,(08):112-128. 被引量:1
-
4SLATTERY M L,HERRICK J S,BONDURANT K L. Toll-like receptor genes and their association with colon and rectal can cer development and prognosis[J].{H}International Journal of Cancer,2012,(12):2974-2980. 被引量:1
-
5FERLAY J,PARKIN D M,STELIAROVA FOUCHER E. Estimates of cancer incidence and mortality in Europe in 2008[J].{H}EUROPEAN JOURNAL OF CANCER,2010,(04):765-781. 被引量:1
-
6HOLD G L,RABKIN C S,CHOW W H. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors[J].{H}GASTROENTEROLOGY,2007,(03):905-912. 被引量:1
-
7SHUI I M,STARK J R,PENNEY K L. Genetic variation in the Toll-like receptor 4 and prostate cancer incidence and morta lity[J].{H}PROSTATE,2012,(02):209-216. 被引量:1
-
8YANG C X,LI C Y,FENG W. Toll-like receptor 4 genetic variants and prognosis of breast cancer[J].{H}Tissue Antigens,2013,(04):221-226. 被引量:1
-
9EYKING A,EY B,RUNZI M. Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer[J].{H}GASTROENTEROLOGY,2011,(06):2154-2165. 被引量:1
-
10OZAKYOL A,OZDEMIR M,ARTAN S. Fish detected p53 deletion and N-MYC amplification in colorectal cancer[J].Hepa togastroenterology,2006,(68):192-195. 被引量:1
-
1闫新星,王晶,克晓燕.Toll样受体与血液恶性肿瘤[J].肿瘤研究与临床,2015,27(11):788-790. 被引量:1
-
2杨震宇,张旭,吕福华.Toll样受体和前列腺癌[J].中国肿瘤临床与康复,2009,16(6):568-570.
-
3杜宇琛,林苹.肿瘤树突状细胞疫苗治疗的临床研究进展[J].四川肿瘤防治,2003,16(1):49-52.
-
4欧春麟,张含,孙振强,李桂源,李小玲,李夏雨.Toll样受体与非可控性炎症相关肿瘤[J].中南大学学报(医学版),2015,40(2):202-207. 被引量:4
-
5刘营营,王宇,韩桂萍.Toll样受体4与炎性肠病和结肠癌[J].肿瘤学杂志,2013,19(9):735-738. 被引量:1
-
6康宝丽,陆英,徐增光.Toll样受体在肺癌中的研究进展[J].同济大学学报(医学版),2015,36(3):140-144. 被引量:5
-
7杨丹丽,张迎秋,李媛,秦胜堂.冬凌草甲素对甲状腺癌BCPAP细胞增殖的抑制作用[J].大连医科大学学报,2016,38(4):330-333. 被引量:7
-
8燕东亮,刘丽.NF-κB与TNF的抗肿瘤作用[J].国外医学(肿瘤学分册),2000,27(3):144-146. 被引量:4
-
9王燕,张翠(综述),张清媛(审校).Toll样受体和肿瘤的关系[J].实用肿瘤学杂志,2013,27(2):190-192.
-
10任文波,黄晶,雷连成.IFN-γ与乳腺癌发生发展关系的研究进展[J].山东医药,2017,57(13):101-103. 被引量:5